Gilead Sciences to Present at Upcoming Investor Conferences

Biopharmaceutical company to share updates at major healthcare industry events.

Published on Feb. 24, 2026

Got story updates? Submit your updates here. ›

Gilead Sciences, Inc., a leading biopharmaceutical company, announced that its executives will be speaking at several upcoming investor conferences, including the TD Cowen Annual Health Care Conference, Leerink Partners Global Healthcare Conference, and Barclays Annual Global Healthcare Conference.

Why it matters

As a major player in the pharmaceutical industry, Gilead's participation in these high-profile investor conferences signals the company's continued growth and innovation in areas like HIV, viral hepatitis, COVID-19, and cancer treatments. Investors and analysts will be closely watching for any updates on Gilead's pipeline and strategic direction.

The details

Gilead's executives will be presenting at the following investor conferences in March 2026: the TD Cowen Annual Health Care Conference on March 3, the Leerink Partners Global Healthcare Conference on March 10, and the Barclays Annual Global Healthcare Conference on March 11. The live webcasts of these presentations will be available on Gilead's investor relations website, and the replays will be accessible for at least 30 days following each event.

  • Gilead's executives will present at the TD Cowen Annual Health Care Conference on Tuesday, March 3 at 11:10 AM Eastern Time.
  • Gilead's executives will present at the Leerink Partners Global Healthcare Conference on Tuesday, March 10 at 11:20 AM Eastern Time.
  • Gilead's executives will present at the Barclays Annual Global Healthcare Conference on Wednesday, March 11 at 11:00 AM Eastern Time.

The players

Gilead Sciences, Inc.

A biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. Gilead is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be closely watching Gilead's presentations at these upcoming conferences for any updates on the company's pipeline, strategic direction, and financial performance.

The takeaway

Gilead's participation in these high-profile investor conferences underscores the company's continued leadership and innovation in the biopharmaceutical industry, as it works to develop and bring to market new treatments for some of the world's most pressing health challenges.